Dirk Huebner
Technik-/Wissenschafts-/F&E-Leiter bei APTEVO THERAPEUTICS INC.
Profil
Dirk Huebner is currently the Chief Medical Officer at Aptevo Therapeutics, Inc. He previously worked as the Executive Medical Director at Millennium Pharmaceuticals, Inc. from 2011 to 2017, as the Vice President at Boston Biomedical, Inc. from 2017 to 2018, and as the Chief Medical Officer at Mersana Therapeutics, Inc. from 2018 to 2020.
He holds a doctorate degree from Freie Universität Berlin.
Aktive Positionen von Dirk Huebner
| Unternehmen | Position | Beginn |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Dirk Huebner
| Unternehmen | Position | Ende |
|---|---|---|
| MERSANA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.11.2020 |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The private company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Corporate Officer/Principal | 01.11.2018 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.08.2017 |
Ausbildung von Dirk Huebner
| Freie Universität Berlin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| APTEVO THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The private company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
